Daniel Globisch

SciLifeLab Fellow since 2015.

Primary: Shown in the list of current labels.

Year 2024

Characterising and preventing the gut microbiota's inactivation of trifluridine, a colorectal cancer drug.
McCoubrey LE, Shen C, Mwasambu S, ..., Globisch D, Basit AW
Eur J Pharm Sci 203 (-) 106922 [2024-12-01; online 2024-10-03]
Daniel Globisch
Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib.
Zhang X, Rameika N, Zhong L, ..., Globisch D, Sjöblom T
EBioMedicine 109 (-) 105368 [2024-11-00; online 2024-10-04]
Daniel Globisch

Year 2023

Year 2022

A Universal Language for Finding Mass Spectrometry Data Patterns
Jarmusch AK, Aron AT, Petras D, ..., Dorrestein PC, Wang M
- - (-) - [2022-08-07; online 2022-08-07]
Daniel Globisch SciLifeLab Fellow

Year 2021

Year 2020

Year 2019

Year 2018

Year 2017

Year 2016

Glycation Reactivity of a Quorum-Sensing Signaling Molecule.
Tsuchikama K, Gooyit M, Harris TL, ..., Kaufmann GF, Janda KD
Angew. Chem. Int. Ed. Engl. 55 (12) 4002-4006 [2016-03-14; online 2016-02-17]
Daniel Globisch SciLifeLab Fellow

Year 2015

Flagellin as carrier and adjuvant in cocaine vaccine development.
Lockner JW, Eubanks LM, Choi JL, ..., Wilson IA, Janda KD
Mol. Pharm. 12 (2) 653-662 [2015-02-02; online 2015-01-07]
Daniel Globisch SciLifeLab Fellow

Year 2013

Year 2012

Year 2011

Year 2010

A Novel Synthetic Route for the Anti-HIV Drug MC-1220 and its Analogues
Loksha YM, Globisch D, Loddo R, ..., La Colla P, Pedersen EB
ChemMedChem 5 (11) 1847-1849 [2010-11-08; online 2010-08-16]
Daniel Globisch SciLifeLab Fellow

Year 2009

Year 2008


Publications 9.5.1